Introduction: The necessity of lymphadenectomy remains controversial in patients with early ovarian cancer. This study aimed to estimate the prevalence of lymph node metastasis (LNM) in patients with apparent local epithelial ovarian cancer (EOC) and to develop a risk model for the prediction of LNM in local EOC with machine learning algorithms.
Materials And Methods: A cohort of 4110 patients who underwent lymphadenectomy with apparent local EOC were retrospectively evaluated. In the model development, a least absolute shrinkage and selection operator (LASSO)-derived Cox regression with internal 10-fold cross-validation was used to identify the risk factors of LNM. Clinical performance was assessed using the decision curve analysis, and a nomogram-based analysis was used to identify the risk factors for LNM.
Results: The incidence rate of LNM was rare in our cohort, at 7.4% (213/2885) in the primary set and 4.8% (59/1225) in the validation set. After feature selection, 10-fold internal validation, and external validation, our risk model performed well in both the discrimination (area under the curve=0.790 in the primary set and area under the curve=0.752 in the validation set) and the Hosmer-Lemeshow tests (P=0.873 in the primary set and P=0.380 in the validation set). Additionally, decision curve analysis demonstrated the superiority of our model for clinical interventions in daily practice.
Conclusion: LNM is rare in patients with local EOC. In our study, which is based on machine learning algorithms, we developed a prediction model to identify patients with local EOC who could benefit from lymphadenectomy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/JS9.0000000000000065 | DOI Listing |
Proteomics Clin Appl
January 2025
Department of Oncology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy which mainly consists of serous, mucinous, clear cell, and endometrioid subtypes. Due to the lack of classic symptoms at an early stage, EOC usually presented as advanced tumors with local and/or distant metastasis. Although a large portion of EOC was initially platinum-sensitive, most patients would acquire resistance to common chemotherapeutic agents.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Life Technologies, Division of Biotechnology, University of Turku, Medisiina D, 5th floor, Kiinamyllynkatu 10, 20520, Turku, Finland.
Glycosylation changes of circulating proteins carrying the CA19-9 antigen may offer new targets for detection methods to be explored for the diagnosis of epithelial ovarian cancer (EOC). Search for assay designs for targets initially captured by a CA19-9 antigen reactive antibody from human body fluids by probing with fluorescent nanoparticles coated with lectins or antibodies to known EOC associated proteins. CA19-9 antigens were immobilized from ascites fluids, ovarian cyst fluids or serum samples using monoclonal antibody C192 followed by probing of carrier proteins using anti-MUC16, anti-MUC1 and, anti STn antibodies and seven lectins, all separately coated on nanoparticles.
View Article and Find Full Text PDFClin Transl Radiat Oncol
March 2025
Department of Radiation Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
Purpose: In prostate cancer patients, high radiation doses to the urethra have been associated with an increased risk of severe genitourinary toxicity following dose-escalated radiotherapy. Urethra-sparing techniques have emerged as a promising approach to reduce urinary toxicity. This international survey aims to evaluate current global practices in urethra-sparing and explore future directions for the implementation of this technique in external beam radiotherapy (EBRT) for prostate cancer.
View Article and Find Full Text PDFRev Panam Salud Publica
January 2025
Ministry of Health Brasília Brazil Ministry of Health, Brasília, Brazil.
Objective: To describe the Brazilian experience of responding to public health emergencies in 2023, the organizational structure, and epidemiological characteristics.
Methods: Three emergencies (case studies) that occurred during the study year were analyzed according to the actions implemented during the response and the impacts on the population. The public health emergencies were summarized and analyzed through research on official documents and websites of the Ministry of Health and local health authorities.
Prostate Cancer Prostatic Dis
January 2025
South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, Australia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!